# CHRDL1

## Overview
CHRDL1 is a gene that encodes the protein chordin-like 1, also known as ventroptin, which is a secreted glycoprotein functioning primarily as a bone morphogenetic protein (BMP) antagonist. This protein is characterized by its cysteine-rich von Willebrand factor type C domains, which facilitate its interaction with BMPs, such as BMP4 and BMP6, thereby inhibiting their signaling pathways (Webb2012XLinked; Itoh2010Secreted). The inhibition of BMP signaling by chordin-like 1 is crucial for regulating various biological processes, including osteogenesis, neural differentiation, and adipogenesis (Ahn2023Chordinlike; GAO2013Chordinlike; Liu2019ChordinLike). Mutations in the CHRDL1 gene are associated with X-linked megalocornea (MGC1) and potentially with megalocornea-mental retardation (MMR) syndrome, highlighting its clinical significance in ocular development and other physiological processes (Davidson2014Association; Webb2012XLinked).

## Structure
The CHRDL1 gene encodes a protein known as ventroptin, which functions as a bone morphogenetic protein (BMP) antagonist. The protein is characterized by the presence of cysteine-rich domains, specifically von Willebrand factor type C domains, which are crucial for its interaction with BMPs (Webb2012XLinked; Itoh2010Secreted). CHRDL1 contains three such cysteine-rich domains, which are essential for its role in modulating BMP signaling (Itoh2010Secreted). These domains allow CHRDL1 to bind to BMPs like BMP4 and BMP6, inhibiting their activity (Itoh2010Secreted).

The protein is secreted and undergoes alternative splicing, resulting in long and short transcript forms that differ in their C-terminal regions but maintain the same three cysteine-rich domains (Itoh2010Secreted). CHRDL1 is also known by other names, including Neuralin 1, Ventroptin, and Neurogenesin 1, reflecting its diverse roles and expression patterns (Itoh2010Secreted). The protein's structure and function are conserved across vertebrates, although no orthologs have been identified in Drosophila, suggesting a possible gene loss in certain lineages (Itoh2010Secreted). The specific post-translational modifications of CHRDL1, such as glycosylation, are not detailed in the provided context.

## Function
CHRDL1 (chordin-like 1) is a secreted glycoprotein that functions as an antagonist to bone morphogenetic proteins (BMPs), particularly BMP-4, by binding to them and inhibiting their signaling pathways. This interaction is crucial for regulating various cellular processes, including osteogenesis and neural differentiation. In the context of bone formation, CHRDL1 enhances osteogenesis in human bone marrow mesenchymal stem cells (hBMSCs) by potentiating the BMP-4-SMAD signaling pathway. It increases the phosphorylation of SMAD-1/5/9, which is a key event in this pathway, thereby promoting the expression of osteogenic markers such as ALP, COL1A1, OPN, and OCN (Liu2019ChordinLike).

In neural stem cells, CHRDL1 promotes neuronal differentiation by inhibiting BMP-4, which reduces Smad5 protein levels, suggesting its role in the BMP-4/Smad5 signaling pathway (GAO2013Chordinlike). CHRDL1 is also involved in adipogenesis, where it acts as a novel adipokine predominantly expressed in white adipose tissue, promoting adipogenesis and lipid accumulation (Ahn2023Chordinlike). These functions highlight CHRDL1's role in modulating BMP signaling, impacting bone, neural, and adipose tissue development and maintenance.

## Clinical Significance
Mutations in the CHRDL1 gene are primarily associated with X-linked megalocornea (MGC1), a condition characterized by an enlarged corneal diameter and deep anterior chamber present at birth. This condition can lead to mosaic corneal degeneration, presenile cataracts, and secondary glaucoma (Pfirrmann2015Molecular; Webb2012XLinked). Various types of mutations in CHRDL1, including frameshift, nonsense, missense, and splice-site mutations, have been identified in individuals with MGC1, and these mutations are not found in control X chromosomes, indicating their specificity to the condition (Webb2012XLinked).

CHRDL1 mutations have also been linked to megalocornea-mental retardation (MMR) syndrome, suggesting a potential multigenic nature of this condition. A novel missense mutation in CHRDL1 was identified in a male patient with MMR syndrome, although the extraocular features such as developmental delay are not typically associated with CHRDL1 mutations (Davidson2014Association; Casasnovas-Nieves2023Mechanisms).

Alterations in CHRDL1 expression can disrupt bone morphogenetic protein (BMP) signaling pathways, which are crucial for ocular development. This disruption can lead to premature corneal development and affect the growth and differentiation of limbal stem cells, potentially contributing to conditions like cataracts (Pfirrmann2015Molecular).

## Interactions
CHRDL1, also known as chordin-like 1, is a secreted glycoprotein that primarily interacts with bone morphogenetic proteins (BMPs), particularly BMP4, to inhibit their signaling. This interaction is crucial in regulating developmental processes and tissue homeostasis. CHRDL1 acts as a BMP antagonist by binding to BMP4, thereby preventing BMP4 from interacting with its receptors. This antagonistic action is significant in various biological contexts, including ocular and neural development (Liu2024Chrdl1mediated; Pfirrmann2015Molecular).

In the context of eye development, CHRDL1's interaction with BMP4 is essential for maintaining the balance of BMP signaling, which is crucial for proper ocular development and preventing conditions such as X-linked megalocornea (XMC). The loss of CHRDL1 function leads to an imbalance in BMP signaling, favoring BMP activity and contributing to the XMC phenotype (Pfirrmann2015Molecular).

In neural stem cells, CHRDL1 promotes neuronal differentiation by inhibiting BMP4, which otherwise promotes astrocyte differentiation. This interaction shifts the differentiation potential of neural stem cells from gliogenesis to neurogenesis, highlighting CHRDL1's role in neural development and potential therapeutic applications in spinal cord injuries (GAO2013Chordinlike).


## References


[1. (Davidson2014Association) Alice E. Davidson, Sek-Shir Cheong, Pirro G. Hysi, Cristina Venturini, Vincent Plagnol, Jonathan B. Ruddle, Hala Ali, Nicole Carnt, Jessica C. Gardner, Hala Hassan, Else Gade, Lisa Kearns, Anne Marie Jelsig, Marie Restori, Tom R. Webb, David Laws, Michael Cosgrove, Jens M. Hertz, Isabelle Russell-Eggitt, Daniela T. Pilz, Christopher J. Hammond, Stephen J. Tuft, and Alison J. Hardcastle. Association of chrdl1 mutations and variants with x-linked megalocornea, neuhäuser syndrome and central corneal thickness. PLoS ONE, 9(8):e104163, August 2014. URL: http://dx.doi.org/10.1371/journal.pone.0104163, doi:10.1371/journal.pone.0104163. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0104163)

[2. (Casasnovas-Nieves2023Mechanisms) José J. Casasnovas-Nieves, Yacidzohara Rodríguez, Hector L. Franco, and Carmen L. Cadilla. Mechanisms of regulation of the chrdl1 gene by the twist2 and add1/srebp1c transcription factors. Genes, 14(9):1733, August 2023. URL: http://dx.doi.org/10.3390/genes14091733, doi:10.3390/genes14091733. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14091733)

[3. (Itoh2010Secreted) Nobuyuki Itoh and Hiroya Ohta. Secreted bone morphogenetic protein antagonists of the chordin family. BioMolecular Concepts, 1(3–4):297–304, October 2010. URL: http://dx.doi.org/10.1515/bmc.2010.026, doi:10.1515/bmc.2010.026. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/bmc.2010.026)

[4. (GAO2013Chordinlike) WEI-LU GAO, SHENG-QUAN ZHANG, HUI ZHANG, BO WAN, and ZONG-SHENG YIN. Chordin-like protein 1 promotes neuronal differentiation by inhibiting bone morphogenetic protein-4 in neural stem cells. Molecular Medicine Reports, 7(4):1143–1148, February 2013. URL: http://dx.doi.org/10.3892/mmr.2013.1310, doi:10.3892/mmr.2013.1310. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2013.1310)

[5. (Liu2024Chrdl1mediated) Dongmei Liu, Zeyuan Pu, Baige Li, Gao Tan, Ting Xie, and Yin Shen. Chrdl1-mediated bmp4 inhibition disrupts the balance between retinal neurons and müller glia. Cell Death Discovery, August 2024. URL: http://dx.doi.org/10.1038/s41420-024-02129-6, doi:10.1038/s41420-024-02129-6. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-024-02129-6)

[6. (Ahn2023Chordinlike) Jinsoo Ahn, Yeunsu Suh, and Kichoon Lee. Chordin-like 1, a novel adipokine, markedly promotes adipogenesis and lipid accumulation. Cells, 12(4):624, February 2023. URL: http://dx.doi.org/10.3390/cells12040624, doi:10.3390/cells12040624. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12040624)

[7. (Webb2012XLinked) Tom R. Webb, Mar Matarin, Jessica C. Gardner, Dan Kelberman, Hala Hassan, Wei Ang, Michel Michaelides, Jonathan B. Ruddle, Craig E. Pennell, Seyhan Yazar, Chiea C. Khor, Tin Aung, Mahinda Yogarajah, Anthony G. Robson, Graham E. Holder, Michael E. Cheetham, Elias I. Traboulsi, Anthony T. Moore, Jane C. Sowden, Sanjay M. Sisodiya, David A. Mackey, Stephen J. Tuft, and Alison J. Hardcastle. X-linked megalocornea caused by mutations in chrdl1 identifies an essential role for ventroptin in anterior segment development. The American Journal of Human Genetics, 90(2):247–259, February 2012. URL: http://dx.doi.org/10.1016/j.ajhg.2011.12.019, doi:10.1016/j.ajhg.2011.12.019. This article has 58 citations.](https://doi.org/10.1016/j.ajhg.2011.12.019)

[8. (Pfirrmann2015Molecular) Thorsten Pfirrmann, Denise Emmerich, Peter Ruokonen, Dagmar Quandt, Renate Buchen, Björn Fischer-Zirnsak, Jochen Hecht, Peter Krawitz, Peter Meyer, Eva Klopocki, Sigmar Stricker, Ekkehart Lausch, Barbara Seliger, Thomas Hollemann, Thomas Reinhard, Claudia Auw-Haedrich, Bernhard Zabel, Katrin Hoffmann, and Pablo Villavicencio-Lorini. Molecular mechanism of chrdl1-mediated x-linked megalocornea in humans and in xenopus model. Human Molecular Genetics, 24(11):3119–3132, February 2015. URL: http://dx.doi.org/10.1093/hmg/ddv063, doi:10.1093/hmg/ddv063. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddv063)

[9. (Liu2019ChordinLike) Tao Liu, Bo Li, Xin-Feng Zheng, Sheng-Dan Jiang, Ze-Zhu Zhou, Wen-Ning Xu, Huo-Liang Zheng, Chuan-Dong Wang, Xiao-Ling Zhang, and Lei-Sheng Jiang. Chordin-like 1 improves osteogenesis of bone marrow mesenchymal stem cells through enhancing bmp4-smad pathway. Frontiers in Endocrinology, June 2019. URL: http://dx.doi.org/10.3389/fendo.2019.00360, doi:10.3389/fendo.2019.00360. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2019.00360)